Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) on Tuesday, plunged -5.14% from the previous trading day, before settling in for the closing price of $112.55. Within the past 52 weeks, RYTM’s price has moved between $45.90 and $122.20.
Annual sales at Healthcare sector company slipped by -2.34% over the past five years. The company achieved an average annual earnings per share of 27.00%. With a float of $62.33 million, this company’s outstanding shares have now reached $66.68 million.
Rhythm Pharmaceuticals Inc (RYTM) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rhythm Pharmaceuticals Inc is 6.60%, while institutional ownership is 106.34%. The most recent insider transaction that took place on Dec 11 ’25, was worth 371,850. In this transaction Chief Human Resources Officer of this company sold 3,350 shares at a rate of $111.00, taking the stock ownership to the 20,814 shares. Before that another transaction happened on Dec 11 ’25, when Company’s Officer proposed sale 3,350 for $104.77, making the entire transaction worth $350,980.
Rhythm Pharmaceuticals Inc (RYTM) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.72 earnings per share (EPS) for the period topping the consensus outlook (set at -0.73) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.00% per share during the next fiscal year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Rhythm Pharmaceuticals Inc (RYTM) is currently performing well based on its current performance indicators. A quick ratio of 4.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 40.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.10, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -2.69 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) saw its 5-day average volume 0.59 million, a negative change from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 26.06%.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 53.20%, which indicates a significant increase from 30.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 5.28 in the past 14 days, which was higher than the 4.10 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $107.00, while its 200-day Moving Average is $85.04. Nevertheless, the first resistance level for the watch stands at $111.96 in the near term. At $117.17, the stock is likely to face the second major resistance level. The third major resistance level sits at $120.15. If the price goes on to break the first support level at $103.78, it is likely to go to the next support level at $100.80. The third support level lies at $95.59 if the price breaches the second support level.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
Market capitalization of the company is 7.12 billion based on 66,736K outstanding shares. Right now, sales total 130,130 K and income totals -260,600 K. The company made 51,300 K in profit during its latest quarter, and -52,900 K in sales during its previous quarter.
